Hisamitsu Pharmaceutical Co (TSE:4530) Short-Term Capital Lease Obligation : 円0 Mil (As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Short-Term Capital Lease Obligation?

Hisamitsu Pharmaceutical Co's Short-Term Capital Lease Obligation for the quarter that ended in Nov. 2023 was 円0 Mil.

Hisamitsu Pharmaceutical Co's annual Short-Term Capital Lease Obligation increased from Feb. 2022 (円301 Mil) to Feb. 2023 (円327 Mil) and increased from Feb. 2023 (円327 Mil) to Feb. 2024 (円350 Mil).

Hisamitsu Pharmaceutical Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Short-Term Capital Lease Obligation Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

68.00

101.00

301.00

327.00

350.00

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															327.00	-	-	-	350.00

Hisamitsu Pharmaceutical Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Hisamitsu Pharmaceutical Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines